DMA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium

Journal of Nanoscience and Nanotechnology

Volumn 5, Issue 8, 2005, Pages 1204-1210

  Wu, Lin ^a   Diao, Zhenyu ^b   Deng, Xiaozhao ^b   Gao, Jian ^b   Zhou, Zongan ^b   Liu, Yu ^b   Wang, Yuanlun ^b  

^a NANJING NORMAL UNIVERSITY   (China)

^b HUADONG RESEARCH INSTITUTE FOR MEDICINE AND BIOTECHNICS   (China)

Author keywords

Cysticercosis; DNA Vaccine; HBcAg; Taenia Solium; Vaccine

Indexed keywords

CYSTICERCOSIS; DNA VACCINE; HBCAG; TAENIA SOLIUM;

ANTIGENS; DISEASES; DNA; IMMUNOLOGY; MOLECULAR WEIGHT; PROTEINS;

VACCINES;

DNA VACCINE; EPITOPE; HELMINTH ANTIBODY; HELMINTH PROTEIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; PARASITE ANTIGEN; RECOMBINANT DNA; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYSTICERCOSIS; ESCHERICHIA COLI; FEMALE; GENE VECTOR; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; NANOTECHNOLOGY; NUCLEOTIDE SEQUENCE; PARASITOLOGY; TAENIA; TAENIA SOLIUM;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BASE SEQUENCE; CYSTICERCOSIS; DNA, RECOMBINANT; EPITOPES; ESCHERICHIA COLI; FEMALE; GENETIC VECTORS; HELMINTH PROTEINS; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NANOTECHNOLOGY; RECOMBINANT PROTEINS; TAENIA; TAENIA SOLIUM; VACCINES, DNA;

EID: 32944474630     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2005.221     Document Type: Article

References (37)

1. A. C. White, Jr., Annu. Rev. Med. 51, 187 (2000).
2. J. G. Burneo and H. H. García, Emedical. 3, 1 (2001).
3. C. G. Gauci and M. W. Lightowlers, Mol. Biochem. Parasitol. 112, 173 (2001).
4. C. G. Gauci, A. Flisser, and M. W. Lightowlers, Int. J. Parasitol. 28, 757 (1998).
5. M. W. Lightowlers, Int. J. Parasitai. 29, 811 (1999).
6. A. Plancarte, A. Plisser, C. G. Gauci, and M. W. Lightowlers, Int. J. Parasitai. 29, 543 (1999).
7. M. Verastegui, R. H. Gilman, A. Gonzales, H. H. Garcia, C. Gavidia, N. Falcon, T. Bernai, Y. Arana, and V. C. Tsang, Vet. Parasitol. 108, 49 (2002).
8. M. Huerta, A. S. de Aluja, G. Fragoso, A. Toledo, N. Villalobos, M. Hemandez, G. Gevorkian, G. Acero, A. Diaz, I. Alvarez, R. Avila, C. Beltran, G. Garcia, J. J. Martinez, C. Larralde, and E. Sciutto, Vaccine 20, 262 (2001).
9. K. Manoutcharian, G. Rosas, M. Hernandez, G. Fragoso, A. Aluja, N. Villalobos, L. F. Rodarte, and E. Sciutto, J. Parasitai. 82, 250 (1996).
10. A. Toledo, C. Larralde, G. Fragoso, G. Gevorkian, K. Manoutcharian, M. Hernandez, G. Acero, G. Rosas, F. Lopez-Casillas, C. K. Garfias, R. Vazquez, I. Terrazas, and E. Sciutto, Infect. Immun. 67, 2522 (1999).
11. A. Toledo, G. Fragoso, G. Rosas, M. Hernandez, G. Gevorkian, F. Lopez-Casillas, B. Hernandez, G. Acero, M. Huerta, C. Larralde, and E. Sciutto, Infect. Immun. 69, 1766 (2001).
12. A. Flisser and M. W. Lightowlers, Mem. Inst. Oswaldo. Cruz. 96, 353 (2001).
13. X. Cai, Z. Chai, Z. Jing, P. Wang, X. Luo, J. Chen, Y. Dou, S. Feng, C. Su, and J. Jin, Southeast Asian J. Trop. Med. Public Health 32, 105 (2001).
14. D. R. Drew, M. Lightowlers, and R. A. Strugnell, Vaccine 18, 692 (1999).
15. C. Cruz-Revilla, G. Rosas, G. Fragoso, F. Lopez-Casillas, A. Toledo, C. Larralde, and E. Sciutto, J. Parasitol 86, 67 (2000).
16. G. Rosas, C. Cruz-Revilla, G. Fragoso, F. Lopez-Casillas, A. Perez, M. A. Bonilla, R. Rosales, and E. Sciutto, J. Parasitol. 84, 516 (1998).
17. K. Manoutcharian, L. I. Terrazas, G. Gevorkian, and T. Govezensky, Immunol. Lett. 62, 131 (1998).
18. J. S. Rothel, J. G. Waterkeyn, R. A. Strugnell, P. R. Wood, H. F. Seow, J. Vadolas, and M. W. Lightowlers, Immunol. Cell. Biol. 75, 41 (1997).
19. Q. M. Wang, S. H. Sun, Z. L. Hu, D. Wu, and Z. C. Wang, Vaccine 21, 1672 (2003).
20. R. Arnon and T. Ben-Yedidia, Int. Immunopharmacol. 3, 1195 (2003).
21. G. Gevorkian, K. Manoutcharian, C. Larralde, M. Hernandez, J. C. Almagro, M. Viveros, J. Sotelo, E. Garcia, and E. Sciutto, Immunol. Lett. 49, 185 (1996).
22. B. E. Clarke, S. E. Newton, A. R. Carroll, M. J. Francis, G. Appleyard, A. D. Syred, P. E. Highfield, D. J. Rowlands, and F. Brown, Nature 330, 381 (1987).
23. B. E. Clarke, A. L. Brown, K. G. Grace, G. Z. Hastings, F. Brown, D. J. Rowlands, and M. J. Francis, J. Gen. Virol. 71, 1109 (1990).
24. N. Ibrahim and M. A. McCrae, Biotech. Lett. 23, 643 (2001).
25. H. Wizemann, F. Weiland, E. Pfaff, and A. von Brunn, Biol. Chem. 381, 231 (2000).
26. M. G. Isaguliants, S. Nordlund, M. Sallberg, V. D. Smirnov, U. Ruden, and B. Wahren, Immuno. Lett. 52, 37 (1996).
27. R. W. Tindle, K. Herd, P. Londono, G. J. Fernando, S. N. Chatfield, K. Malcolm, and G. Dougan, Virology 200, 547 (1994).
28. P. Pumpens and E. Grens, FEBS Lett. 442, 1 (1999).
29. G. Borisova, W. O. Borschukova, G. Mezule, D. Skrastina, I. Petrovskis, A. Dislers, P. Pumpens, and E. Grens, Intervirology 39, 16 (1996).
30. L. F. Wang, M. Yu, E. Hansson, L. I. Pritchard, B. Shiell, W. P. Michalski, and B. T. Eaton, J. Virol. 74, 9972 (2000).
31. K. F. Hoffmann, S. L. James, A. W. Cheever, and T. A. Wynn, J. Immunol. 163, 927 (1999).
32. D. Jankovic, T. A. Wynn, M. C. Kullberg, S. Hieny, P. Caspar, S. James, A. W. Cheever, and A. Sher, J. Immunol. 162, 345 (1999).
33. B. Bottcher, S. A. Wynne, and R. A. Crowther, Nature 386, 88 (1997).
34. F. Schodel, D. Peterson, and D. Milich, Intervirology 39, 104 (1996).
35. A. Zlotnick, N. Cheng, S. J. Stahl, J. F. Conway, A. C. Steven, and P. T. Wingfield, Proc. Natl. Acad. Sci. USA. 94, 9556 (1997).
36. D. R. Milich, J. Hughes, J. Jones, M. Sallberg, and T. R. Phillips, Vaccine 20, 771 (2001).
37. F. Schodel, A. M. Moriarty, D. L. Peterson, J. A. Zheng, J. L. Hughes, H. Will, D. J. Leturcq, J. S. McGee, and D. R. Milich, J. Virol. 66, 106 (1992).